Home
ホーム
Our Company
About Us
Leadership
Careers
会社案内
弊社について
リーダーシップ
採用情報
Our Focus
Low Back Pain
Cell Therapy
開発領域
腰痛について
細胞治療
Patients & Families
Degenerative Disc Disease
Clinical Trials
Expanded Access Policy
患者様へ
椎間板変性について
臨床試験情報
Research & Development
Discogenic Cells
IDCT
Product Pipeline
Intellectual Property
Scientific Publications
研究開発
ディスコジェニック細胞について
IDCT
パイプライン
知的財産
出版物
Investors & Media
Press Releases
Events & Presentations
In the News
CEO's Blog
投資家・メディアの方へ
ニュース
イベント情報
ブログ
Contact
お問い合わせ
日本語
English

DiscGenics

Home
ホーム
Our Company
About Us
Leadership
Careers
会社案内
弊社について
リーダーシップ
採用情報
Our Focus
Low Back Pain
Cell Therapy
開発領域
腰痛について
細胞治療
Patients & Families
Degenerative Disc Disease
Clinical Trials
Expanded Access Policy
患者様へ
椎間板変性について
臨床試験情報
Research & Development
Discogenic Cells
IDCT
Product Pipeline
Intellectual Property
Scientific Publications
研究開発
ディスコジェニック細胞について
IDCT
パイプライン
知的財産
出版物
Investors & Media
Press Releases
Events & Presentations
In the News
CEO's Blog
投資家・メディアの方へ
ニュース
イベント情報
ブログ
Contact
お問い合わせ
日本語
English
shutterstock_404152939.jpg

DiscGenics In the News

  • Investors & Media
  • Press Releases
  • Events & Presentations
  • In the News
  • CEO's Blog
Featured
Jul 17, 2024
FDA grants approval to DiscGenics for Phase III trial of cell therapy
Jul 17, 2024

Clinical Trials Arena

Read More →
Jul 17, 2024
Jul 9, 2024
Discgenics’ cell therapy on phase III track for disc degeneration
Jul 9, 2024

BioWorld

Read More →
Jul 9, 2024
Mar 25, 2024
Noninvasive Injectables for Chronic Low Back Pain
Mar 25, 2024

IEEE Pulse

Read More →
Mar 25, 2024
Sep 5, 2023
A Revolutionary Approach to Treating Degenerative Disc Disease: Merge Medical Podcast with DiscGenics
Sep 5, 2023

Merge Medical Podcast

Read More →
Sep 5, 2023
Jul 17, 2023
A New Era in Spinal Care: FORCE Family Office Fireside Chat with DiscGenics and Piper Sandler
Jul 17, 2023

FORCE Family Office Webinar

Read More →
Jul 17, 2023
May 3, 2023
Force Family Office Fireside Chat: Expert Panel Discusses DiscGenics’ Potential Cure for Degenerative Disc Disease
May 3, 2023

FORCE Family Office Webinar

Read More →
May 3, 2023
Apr 13, 2023
Achieving Regeneration in Lumbar Degenerative Disc Disease
Apr 13, 2023

CGTLive

Read More →
Apr 13, 2023
Feb 27, 2023
High-dose allogeneic disc progenitor cells may improve low back pain
Feb 27, 2023

Orthopedics Today

Read More →
Feb 27, 2023
Feb 7, 2023
DiscGenics receives FDA RMAT designation for IDCT for degenerative disc disease
Feb 7, 2023

Spinal News International

Read More →
Feb 7, 2023
Jan 26, 2023
Discogenic Progenitor Cell Therapy Shows Improvements in Lumbar Degenerative Disc Disease, Recognized by FDA
Jan 26, 2023

CGTLive

Read More →
Jan 26, 2023
Feb 28, 2022
DiscGenics reports positive Phase I/II data from degenerative disc disease trial
Feb 28, 2022

Clinical Trials Arena

Read More →
Feb 28, 2022
Feb 28, 2022
DiscGenics Touts Positive Clinical Data for DDD Cell Therapy
Feb 28, 2022

Orthopedic Design & Technology

Read More →
Feb 28, 2022
Feb 9, 2021
DiscGenics completes construction on Salt Lake City HQ — 7 things to know
Feb 9, 2021

Becker’s Spine Review

Read More →
Feb 9, 2021
Oct 22, 2020
DiscGenics Raises $50 Million For its Novel Back Pain Treatment
Oct 22, 2020

TechBuzz News

Read More →
Oct 22, 2020
Sep 18, 2020
Living Progenitor Cells Edge Closer to "Cure-All" Status
Sep 18, 2020

Orthopedics This Week

Read More →
Sep 18, 2020
Sep 9, 2020
Former Medtronic Spine and Biologics exec appointed DiscGenics CFO
Sep 9, 2020

Becker’s Spine Review

Read More →
Sep 9, 2020
Aug 27, 2020
DiscGenics Raises $50M in Series C Funding
Aug 27, 2020

FinSMEs

Read More →
Aug 27, 2020
Jun 22, 2020
Alleviating chronic back pain: an interview with Isaac Erickson
Jun 22, 2020

RegMedNet

Read More →
Jun 22, 2020
Mar 4, 2020
DiscGenics Announces Completion of Enrollment in U.S. Phase 1/2 Clinical Trial of Discogenic Cell Therapy for Degenerative Disc Disease
Mar 4, 2020

OrthoSpineNews

Read More →
Mar 4, 2020
Feb 26, 2020
Why Cell-Based Therapies Could Be an Alternative to Opioids
Feb 26, 2020

Future of Personal Health

Read More →
Feb 26, 2020
Jan 7, 2020
Japanese study of disc degeneration cell therapy passes safety review
Jan 7, 2020

Spinal News International

Read More →
Jan 7, 2020
Dec 11, 2019
The Top 20 Advanced Therapy Biotechs to Watch in 2020
Dec 11, 2019

Phacilitate

Read More →
Dec 11, 2019
Sep 22, 2019
FDA approves ‘fast track’ for Utah-based DiscGenics
Sep 22, 2019

Deseret News

Read More →
Sep 22, 2019
Sep 17, 2019
Back in the Game: A Look at Spine Innovations
Sep 17, 2019

Orthopedic Design & Technology

Read More →
Sep 17, 2019
Aug 27, 2019
FDA grants fast track designation to cell therapy for degenerative disk disease
Aug 27, 2019

Orthopedics Today

Read More →
Aug 27, 2019
Aug 6, 2018
Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain
Aug 6, 2018

Technology Networks

Read More →
Aug 6, 2018
Apr 27, 2018
Dr. Domagoj Coric treats 1st patient in DiscGenics' trial to treat degenerative disc disease: 5 insights
Apr 27, 2018

Becker’s Spine Review

Read More →
Apr 27, 2018
Oct 22, 2017
A Promising Solution to Lower Back Pain
Oct 22, 2017

Pain News Network

Read More →
Oct 22, 2017
Oct 6, 2017
Utah medical tech firms are trying stem cells to treat back pain and artificial intelligence to develop new drugs
Oct 6, 2017

The Salt Lake Tribune

Read More →
Oct 6, 2017
Jul 15, 2014
What a young girl can learn from Utah women about STEM education and careers
Jul 15, 2014

Deseret News

Read More →
Jul 15, 2014
 
Back to Top

Terms of Use

Privacy Policy